KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Opko Health (OPK) over the last 16 years, with Q2 2025 value amounting to $788.0 million.

  • Opko Health's Shares Outstanding (Weighted Average) rose 1224.59% to $788.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $788.0 million, marking a year-over-year increase of 1224.59%. This contributed to the annual value of $694.0 million for FY2024, which is 768.14% down from last year.
  • Opko Health's Shares Outstanding (Weighted Average) amounted to $788.0 million in Q2 2025, which was up 1224.59% from $671.6 million recorded in Q1 2025.
  • In the past 5 years, Opko Health's Shares Outstanding (Weighted Average) ranged from a high of $788.0 million in Q2 2025 and a low of $640.9 million during Q1 2021
  • For the 5-year period, Opko Health's Shares Outstanding (Weighted Average) averaged around $705.8 million, with its median value being $706.9 million (2024).
  • Its Shares Outstanding (Weighted Average) has fluctuated over the past 5 years, first soared by 1511.92% in 2022, then plummeted by 768.14% in 2024.
  • Over the past 5 years, Opko Health's Shares Outstanding (Weighted Average) (Quarter) stood at $648.1 million in 2021, then rose by 10.95% to $719.1 million in 2022, then grew by 4.55% to $751.8 million in 2023, then dropped by 7.68% to $694.0 million in 2024, then increased by 13.54% to $788.0 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $788.0 million in Q2 2025, compared to $671.6 million in Q1 2025 and $694.0 million in Q4 2024.